# FDA recall D-1083-2018

> **Ranier's Compounding Laboratory** · Class II · drug recall initiated 2018-07-25.

## Product

Triple P (Prostaglandin/Papaverine/Phentolamine) Injection, 0.008/22.5/0.83 mg/mL, packaged in a) 5 mL and b) 10 mL vials, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA 15644.

## Reason for recall

Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

## Distribution

Product was distributed within the state of Pennsylvania.

## Key facts

- **Recall number:** D-1083-2018
- **Recalling firm:** Ranier's Compounding Laboratory
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2018-07-25
- **Report date:** 2018-08-22
- **Termination date:** 2022-09-01

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Jeannette, PA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1083-2018

## Citation

> AI Analytics. FDA recall D-1083-2018. Retrieved 2026-05-28 from https://api.ai-analytics.org/recall/D-1083-2018. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*